je.st
news
FDA expands use of Pfizer drug for rare form of lung cancer
2016-03-11 21:25:28| Biotech - Topix.net
" The Food and Drug Administration expanded approval of a Pfizer drug to treat a small subset of lung cancer patients with a rare mutation. The agency said Friday that Xalkori capsules are now approved for patients with the ROS-1 gene mutation, who make up about 1 percent of U.S. patients with non-small cell lung cancer, the most common form of the disease.
Tags: form
drug
cancer
rare
Category:Biotechnology and Pharmaceuticals